ArticleCancers2024

Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer.

Vahé Barsegian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.